YARROW BIOSCIENCE, INC. Payments of Financing Costs
YARROW BIOSCIENCE, INC. (YARW) reported Payments of Financing Costs of $867.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. payments of financing costs for fiscal 2017 was $867.00K.
- YARROW BIOSCIENCE, INC. payments of financing costs for fiscal 2016 was $0.00.
- YARROW BIOSCIENCE, INC. payments of financing costs for fiscal 2015 was $0.00.
| Period end | Payments of Financing Costs 12 month |
|---|---|
| 2017-12-31 | $867.00K 10-K · filed 2020-03-03 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |